A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bladder Cancer
Related studies linked through entity extraction aliases.
Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer
- Status
- UNKNOWN
- Phase
- N/A
Measurements of Sexual Steroids' Concentrations in Prostatic Tissue
- Status
- COMPLETED
- Phase
- N/A
Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors ("Non-responders") and Non-recurrent Tumors ("Responders") After Intravesical Treatment With Chemotherapy or Immunotherapy
- Status
- UNKNOWN
- Phase
- N/A
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Neoadjuvant Chemotherapy in Non Muscle Invasive T1b Bladder Cancer
- Status
- UNKNOWN
- Phase
- N/A
Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
- Status
- RECRUITING
- Phase
- N/A
Integrated Care Pathway in Oncology (PASSION)
- Status
- UNKNOWN
- Phase
- N/A
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Protocol of the Italian Radical Cystectomy Registry
- Status
- UNKNOWN
- Phase
- N/A
Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study
- Status
- UNKNOWN
- Phase
- NA
Evaluation of Naloxegol in the Prevention of POI After Cystectomy
- Status
- UNKNOWN
- Phase
- PHASE2
Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)
- Status
- COMPLETED
- Phase
- NA
Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
- Status
- RECRUITING
- Phase
- N/A
Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study
- Status
- COMPLETED
- Phase
- NA
Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder
- Status
- COMPLETED
- Phase
- NA